Literature DB >> 20677001

En passant mutagenesis: a two step markerless red recombination system.

B Karsten Tischer1, Gregory A Smith, Nikolaus Osterrieder.   

Abstract

Bacterial artificial chromosomes are used to maintain and modify large sequences of different origins in Escherichia coli. In addition to RecA-based shuttle mutagenesis, Red recombination is commonly used for sequence modification. Since foreign sequences, such as antibiotic resistance genes as well as frt- or loxP-sites are often unwanted in mutant BAC clones, we developed a Red-based technique that allows for the scarless generation of point mutations, deletions, and insertion of smaller and larger sequences. The method employs a sequence duplication that is inserted into the target sequence in the first recombination step and the excision of the selection marker by in vivo I-SceI cleavage and the second Red recombination. To allow for convenient and highly efficient mutagenesis without the use of additional plasmids, the E. coli strain GS1783 with a chromosomal encoded inducible Red- and I-SceI-expression was created.

Entities:  

Mesh:

Year:  2010        PMID: 20677001     DOI: 10.1007/978-1-60761-652-8_30

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  313 in total

1.  The ORF012 gene of Marek's disease virus type 1 produces a spliced transcript and encodes a novel nuclear phosphoprotein essential for virus growth.

Authors:  Timo Schippers; Keith Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  The herpes simplex virus 1 UL17 protein is the second constituent of the capsid vertex-specific component required for DNA packaging and retention.

Authors:  Katerina Toropova; Jamie B Huffman; Fred L Homa; James F Conway
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression.

Authors:  Lauren M Wagner; Jonathan T Lester; Frances L Sivrich; Neal A DeLuca
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

4.  Nuclear egress of pseudorabies virus capsids is enhanced by a subspecies of the large tegument protein that is lost upon cytoplasmic maturation.

Authors:  Mindy Leelawong; Joy I Lee; Gregory A Smith
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

5.  Differentiating the Roles of UL16, UL21, and Us3 in the Nuclear Egress of Herpes Simplex Virus Capsids.

Authors:  Jie Gao; Renée L Finnen; Maxwell R Sherry; Valerie Le Sage; Bruce W Banfield
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

6.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

7.  Herpesvirus saimiri antagonizes nuclear domain 10-instituted intrinsic immunity via an ORF3-mediated selective degradation of cellular protein Sp100.

Authors:  Florian Full; Nina Reuter; Katrin Zielke; Thomas Stamminger; Armin Ensser
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

8.  Influence of Human Cytomegalovirus Glycoprotein O Polymorphism on the Inhibitory Effect of Soluble Forms of Trimer- and Pentamer-Specific Entry Receptors.

Authors:  Nadja Brait; Tanja Stögerer; Julia Kalser; Barbara Adler; Ines Kunz; Max Benesch; Barbara Kropff; Michael Mach; Elisabeth Puchhammer-Stöckl; Irene Görzer
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

9.  Baculovirus AC102 Is a Nucleocapsid Protein That Is Crucial for Nuclear Actin Polymerization and Nucleocapsid Morphogenesis.

Authors:  Susan E Hepp; Gina M Borgo; Simina Ticau; Taro Ohkawa; Matthew D Welch
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

10.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.